Organicin Scientific

Impact

Organicin is building a drug discovery platform that leverages closed-loop system to efficiently develop bacteriocins for niche applications in aquaculture, agriculture and human health.

Society’s overreliance on antibiotics has led to a state of vulnerability within our healthcare and food systems. As antibiotic resistance culminates, this support structure will crumble.

Organicin Scientific uses proprietary machine learning algorithms to accelerate the discovery of novel bacteriocins that are developed into antibiotic alternatives to prevent and treat diseases.

Contact Info

Griffin O'Driscoll
Co-Founder

Margaret Riley
Co-Founder

Contact Us

organicinscientific.com